Get started
Work

Right Ventricular Metrics as End Points in Clinical Trials

Year: 2026
Type: article
DOI: 10.1001/jamacardio.2026.2053
Authors: Elena Surkova, Bálint Lakatos, Hannah Kempton, Alex Pui-Wai Lee, JoAnn Lindenfeld, Joao A. C. Lima, Stephan Rosenkranz, Barry A. Borlaug, Jörg Hausleiter, Daniel Burkhoff, Denisa Muraru, Martin Leon, Béla Merkely, Rebecca T. Hahn, Attila Kovács
Institutions: AstraZeneca (United Kingdom), Guy's and St Thomas' NHS Foundation Trust, Harefield Hospital, Royal Brompton Hospital, Imperial College London, Semmelweis University, LMU Klinikum, Ludwig-Maximilians-Universität München, Chinese University of Hong Kong, Vanderbilt University Medical Center, Johns Hopkins University, Johns Hopkins Medicine, University of Cologne, University Hospital Cologne, Mayo Clinic, Cardiovascular Research Foundation, IRCCS Istituto Auxologico Italiano, University of Milano-Bicocca, Columbia University Irving Medical Center, Columbia University
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7165776498
FWCI:
Cites: 73
Cited by:
Related to: